Close Menu

NEW YORK (GenomeWeb) – HTG Molecular Diagnostics reported after the close of the market on Thursday a 46 percent jump in its full year revenues, driven by the expansion of its biomarker profiling services business and progress on its collaborative programs.

For the year ended Dec. 31, 2018, the firm's revenues rose to $21.5 million from $14.8 million in 2017. Analysts on average had expected full-year revenues of $22.0 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.